Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus
Majid Zeidi, Hee Joo Kim, Victoria P. Werth
Journal of Investigative Dermatology (2018) Vol. 139, Iss. 2, pp. 324-332
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies
Joerg Wenzel
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 9, pp. 519-532
Closed Access | Times Cited: 162
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
Alina Dima, Ciprian Jurcuț, François Chasset, et al.
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 125
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
Jodi L. Karnell, Yanping Wu, Nanette Mittereder, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 595
Closed Access | Times Cited: 76
STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation
Arthid Thim-uam, Thaneas Prabakaran, Mookmanee Tansakul, et al.
iScience (2020) Vol. 23, Iss. 9, pp. 101530-101530
Open Access | Times Cited: 70
Febuxostat therapy in outpatients with suspected COVID‐19: A clinical trial
Lotfollah Davoodi, Seyed Mohammad Abedi, Ebrahim Salehifar, et al.
International Journal of Clinical Practice (2020) Vol. 74, Iss. 11
Open Access | Times Cited: 37
Multidimensional Immune Profiling of Cutaneous Lupus Erythematosus In Vivo Stratified by Patient Response to Antimalarials
Jay Patel, Thomas Vazquez, Felix Chin, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 10, pp. 1687-1698
Open Access | Times Cited: 20
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus
Valeria Erazo-Martínez, Gabriel J. Tobón, Carlos A. Cañas
Autoimmunity Reviews (2022) Vol. 22, Iss. 2, pp. 103262-103262
Closed Access | Times Cited: 19
Deciphering the immunological interactions: targeting preeclampsia with Hydroxychloroquine’s biological mechanisms
Maja Gajić, Bianca Schröder‐Heurich, K Mayer-Pickel
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Synovitis and its association with elevated circulating interferons and hydroxychloroquine response in discoid lupus erythematosus: a cross-sectional study
Małgorzata Stec, Monika Krezelok, Magdalena Awsiuk, et al.
Rheumatology International (2025) Vol. 45, Iss. 3
Closed Access
Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review
François Chasset, Camille Françès
Drugs (2019) Vol. 79, Iss. 11, pp. 1199-1215
Open Access | Times Cited: 31
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM
Spandana Maddukuri, Jay Patel, DeAnna Diaz, et al.
Arthritis Research & Therapy (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus
Thomas Vazquez, Jay Patel, Nilesh Kodali, et al.
Journal of Investigative Dermatology (2023) Vol. 144, Iss. 6, pp. 1262-1272.e7
Closed Access | Times Cited: 9
Lupus-prone NZM2328 mice exhibit enhanced UV-induced myeloid cell recruitment and activation in a type I interferon dependent manner
Mitra P. Maz, Alayka L. Reddy, Céline C. Berthier, et al.
Journal of Autoimmunity (2024) Vol. 149, pp. 103296-103296
Closed Access | Times Cited: 3
Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness
Kristen L. Chen, Jay Patel, Majid Zeidi, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 8, pp. 1906-1914.e2
Open Access | Times Cited: 20
Recent advances in cutaneous lupus
Mitra P. Maz, Jacob W.S. Martens, Andrew Hannoudi, et al.
Journal of Autoimmunity (2022) Vol. 132, pp. 102865-102865
Closed Access | Times Cited: 15
Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know
A. Teboul, Laurent Arnaud, François Chasset
The Journal of Dermatology (2024) Vol. 51, Iss. 7, pp. 895-903
Closed Access | Times Cited: 2
Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries
Krizia Pocino, Valeria Carnazzo, Annunziata Stefanile, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7762-7762
Open Access | Times Cited: 2
Effects of hydroxychloroquine on the mucosal barrier and gut microbiota during healing of mice colitis
Pan Huang, Yan Zhou, Siyu Wang, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 8, pp. 4144-4153
Closed Access | Times Cited: 2
Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus
Kristen L. Chen, Rebecca L. Krain, Victoria P. Werth
F1000Research (2019) Vol. 8, pp. 332-332
Open Access | Times Cited: 19
Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus
Jane L. Zhu, Samantha Black, Benjamin F. Chong
Annals of Translational Medicine (2021) Vol. 9, Iss. 5, pp. 429-429
Open Access | Times Cited: 15
Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials
Darosa Lim, Julianne Kleitsch, Victoria P. Werth
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 4, pp. 257-273
Closed Access | Times Cited: 5
Nucleic Acid Immunity in the Pathogenesis of Cutaneous Lupus Erythematosus
Claudia Günther
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 14
Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus*
Jane L. Zhu, Ly Tran, Miles Smith, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 3, pp. 563-572
Open Access | Times Cited: 12
Management of cutaneous lupus erythematosus
Benjamin F. Chong, Victoria P. Werth
Elsevier eBooks (2024), pp. 802-809
Closed Access | Times Cited: 1
Treatment of discoid lupus with lenalidomide and anifrolumab: Case report and review of the literature
Connor S. Centner, Nicole Robertson, Junren Kang, et al.
Lupus (2024) Vol. 33, Iss. 13, pp. 1487-1491
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top